Skip to main content

Day: April 8, 2024

Caledonia Mining Corporation Plc: Appointment of Chief Operating Officer

ST HELIER, Jersey, April 08, 2024 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that James Mufara (aged 49) has agreed to join the Caledonia group as Chief Operating Officer with effect from May 1, 2024. James was previously at Harmony Gold Mining Company Limited where, as Regional General Manager, he headed a complex portfolio of operations consisting of five mines and 15,000 staff, mining 450koz of gold per annum. James has over 25 years’ experience in the mining sector in Southern Africa, including 13 years in leadership roles. His career has been primarily gold focused, but also with exposure to nickel, copper, and chrome mining. His experience includes deep-level underground mining and open-pit operations,...

Continue reading

SIRONA BIOCHEM Corporate Update April 2024

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) provides the following update: Dear shareholders, We are pleased to provide an update on our recent milestones and strategic decisions shaping Sirona Biochem’s path forward. AGM Last week, during our Annual General Meeting (AGM), we successfully gained another year of backing for our management team. Although it’s common for many shareholders to abstain from voting, we’re pleased to report that we’ve received numerous messages from our shareholders expressing their support for our ongoing corporate strategy. Financing We have closed our financing well below its anticipated goal. The small cap marketplace in the Canadian market is very challenged at this time. Our...

Continue reading

Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024

Planegg/Martinsried, April 8, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents superior recombinant T cell receptor (rTCR) engineered T cell functionality as well as a favorable safety profile when rTCR-T cells are armored and enhanced with the PD1-41BB costimulatory switch protein (CSP) at the American Association for Cancer Research (AACR) Annual Meeting 2024 taking place April 5-10, 2024, in San Diego, USA. The poster presentation with the title “TCR-gated control of costimulatory switch protein (CSP) activation in rTCR-T cells expressing PD1-41BB” is available on Medigene’s website at https://medigene.com/science/abstracts/ Targeting solid tumors with TCR-T therapies still...

Continue reading

CGG’s Long Term Debt Upgraded by S&P

PARIS, France – April 8, 2024  CGG today announced that S&P Global Ratings (“S&P”) has upgraded the Company’s issuer credit rating to ‘B-‘ from ‘CCC+’. S&P noted “a markedly stronger 2024 – 2025 financial performance ” as a reason for the upgrade. “We believe that S&P’s rating upgrade aligns with our recently communicated financial roadmap”, said CGG CFO, Jérôme Serve. “We remain focused on the strengthening of our financial performance, cash generation and balance sheet deleveraging.” Q1 2024 Results and conference call CGG will announce its first quarter 2024 non-audited results on May 14, 2024, after market close. About CGG CGG (www.cgg.com) is a global technology and HPC leader that provides data, products, services and solutions in Earth science, data...

Continue reading

AB Akola Group invests in ‘Brite’, a natural functional drinks start-up

5 April AB Akola Group has signed an agreement with Brite Drinks Ltd, a UK functional drinks start-up, to invest 450 thousand euros. Akola Group will receive a minority stake in the startup and a seat on its board. Brite Drinks Ltd is a Lithuanian-owned manufacturer of ‘Brite’ functional drink, with sales to the United Kingdom, Ireland, Belgium, France, and the Baltic States. “We decided to invest in this start-up because of the growing market, unique product features and the very driven team. Firstly, the global energy drink market is growing at around 8.5% annually and is expected to reach almost USD 174 billion by 2030. Secondly, Brite’s innovative formulation differs from other energy drinks in that it is tailored for mental performance and is completely natural. The guys who started the business are surprisingly hard-working,...

Continue reading

New payment services brand for merchants

Good morning, Bonjour, Please find attached the press release related to the Crédit Agricole and Worldline new payment services brand for merchants.Veuillez trouver ci-joint le communiqué de presse relatif à la nouvelle marque de paiement commerçants de Crédit Agricole et Worldline. Best regards,Bien cordialement, The Investor Relations teamL’équipe Relations InvestisseursAttachmentPR_CAWL_new payment services brand for merchants

Continue reading

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces the completion of patient enrollment in its Phase III clinical trial (NCT05438407) evaluating the investigational drug leniolisib, an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). Leniolisib, marketed under the brand name Joenja® in the U.S., received approval from the US Food and Drug Administration (FDA) for the treatment of APDS in adult and pediatric patients 12 years of age and older in March 2023. Pharming plans to include data from this...

Continue reading

Save the Date: Unifiedpost Group Strategy Update Presentation on 30 April 2024.

Press ReleaseLa Hulpe, Belgium – 8 April 2024, 7:00 a.m. CET – Unifiedpost Group, a leader in cloud-based business process solutions, will present an overview of its mid-term strategy on Tuesday, 30 April 2024. The Strategy Day will be a virtual event. At the event, Hans Leybaert, CEO, and Koen De Brabander, CFO, will present an update on business activities including strategic initiatives for the digital business, as well as the Group’s financial objectives. Other members of the executive team will also present during the day. The event will take place from 2:00pm to 3:30pm CET on Tuesday, 30 April 2024 and will be available to stream via a live webcast. To register your interest for the event, please click the link below to subscribe:https://onlinexperiences.com/Launch/QReg/ShowUUID=69A1FEE7-5AFC-4DC2-BD32-0ED753E88D51 Should you have...

Continue reading

President and CEO of WithSecure steps down; Chief Product Officer Antti Koskela appointed as interim CEO

WithSecure Corporation, Stock Exchange Release, 8 April 2024, 8:15 EEST President and CEO of WithSecure steps down; Chief Product Officer Antti Koskela appointed as interim CEO Juhani Hintikka, President and CEO of WithSecure, has today announced that he steps down from his position in the company. The decision to step down follows the Supreme Court ruling of 5 April 2024 where Juhani Hintikka was found guilty of abuse of inside information related to a matter dating back to 2014, years before Hintikka joined WithSecure. “This decision does not relate to Juhani Hintikka’s tenure at WithSecure at all. Juhani Hintikka has professionally navigated WithSecure through a significant transformation and transition into becoming a leading European cyber security company and I want to warmly thank him for that. Due to the Supreme Court ruling Hintikka...

Continue reading

Brasse, Now Bestla, Brage’s Grandma, to Tie Up with Brage as Partners Approve Field Development                                                                                                                                                 

Oslo, 8 April 2024 – DNO ASA, the Norwegian oil and gas operator, today announced that a final investment decision has been made for the development of the Brasse field, to be renamed Bestla, based on a tie-back to the nearby production facilities of the Brage field. Bestla is Brage’s grandmother in Norse mythology. By long-standing practice, all Norwegian oil and gas fields carry Norse, Nordic or Norwegian names. Bestla (PL740), located in the northern North Sea, is estimated to contain 24 million barrels of oil equivalent (MMboe) in recoverable reserves and is expected to come on stream as early as the first half of 2027, subject to government approval of a plan for development and operation (PDO) to be submitted later this month. In addition to DNO Norge AS (39.3 percent), the Bestla partnership includes OKEA ASA (39.3 percent) as operator,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.